Adventure

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…

2 months ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

2 months ago

Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies

October 24, 2025 23:37 ET  | Source: RepIntel. New York, New York, USA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aletheia…

2 months ago

Andamanda Phuket Ranked in Trip Best 2025 Global Top 100 – A Must-Visit for Indian Families

Offering much more than just beaches, Andamanda Phuket — a Thai mythology-inspired water park — was recently named in Trip Best 2025 – Global…

2 months ago

Salesforce Deepens Impact in India – Reaches Over $10 Million in Grants, 664K Volunteer Hours, Technology Support

Salesforce, the world’s #1 AI CRM*, reaffirmed its commitment to corporate philanthropy in India through its 1-1-1 philanthropy model -…

2 months ago

DongCheng Repeats “Asia’s Top 500 Brands” Honor – Asian Brand Influence on the Rise

NANTONG, China, Oct. 24, 2025 /PRNewswire/ -- On September 24, 2025, the 20th Asia Brand Summit took place in Hong…

2 months ago

Hisense Ignites Global Football Fever in India with FIFA Club World Cup 2025

Hisense, a global leader in consumer electronics and official partner of the FIFA Club World Cup 2025™, is lighting up…

2 months ago

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

October 24, 2025 07:02 ET  | Source: Kura Oncology, Inc. - Milestone triggered by dosing of first patient in frontline…

2 months ago

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

October 24, 2025 07:00 ET  | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…

2 months ago

/C O R R E C T I O N — IFPA/

In the news release, World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis, issued 23-Oct-2025 by…

2 months ago